{"id":58989,"date":"2021-06-28T15:56:08","date_gmt":"2021-06-28T13:56:08","guid":{"rendered":"http:\/\/www.veeva.com\/eu\/?page_id=58989"},"modified":"2026-01-26T22:16:52","modified_gmt":"2026-01-26T21:16:52","slug":"oncology-veeva-edc","status":"publish","type":"page","link":"https:\/\/www.veeva.com\/eu\/oncology-veeva-edc\/","title":{"rendered":"EDC Technologies to Increase Agility in Oncology Trials"},"content":{"rendered":"

<\/p>\n

\n
\n
\n
\n
\n\t\t\t\t\t\n\t\t\t\t<\/div>\n<\/p><\/div>\n
\n
\n

How to Increase
\n\t\t\t\t\t\tAgility in Oncology
\n\t\t\t\t\t \tTrials with Modern EDC<\/h1>\n

Design > Collect > Decide > Act<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/section>\n

<\/p>\n

\n
\n
\n
\n

Clinical trials involve intense clinical decisions that demand fast decisions and action. However, sponsors\u2019 choice of technology constrains their possibilities; often they are forced to run the trial their technology limits them to, not the study they need. EDC technologies must allow for change and flexibility to deliver advanced trial designs faster.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n

\n
\n
\n
\n
\n\t\t\t\t\t\t
\n\t\t\t\t\t\tSimplifying the
Study Design<\/a>\n\t\t\t\t\t<\/div>\n
\n\t\t\t\t\t\t
\n\t\t\t\t\t\tDocumenting the
Patient Journey<\/a>\n\t\t\t\t\t<\/div>\n
\n\t\t\t\t\t\t
\n\t\t\t\t\t\tMaking Informed
Decisions<\/a>\n\t\t\t\t\t<\/div>\n
\n\t\t\t\t\t\t
\n\t\t\t\t\t\tActing with Speed
and Agility<\/a>\n\t\t\t\t\t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n
\n
\n
<\/div>\n<\/p><\/div>\n

\t\t<\/p>\n

\n
\n
\n\t\t\t\t\t\n\t\t\t\t<\/div>\n
\n\t\t\t\t\t<\/a><\/p>\n

DESIGN<\/h3>\n

Simplifying the Study Design in Oncology Trials<\/h2>\n

Protocols for Phase 3 oncology trials are 16% longer and require substantially more review cycles than other drugs (9.7 vs 5.9), due to their greater complexity (Tufts CSDD, 2021). With traditional EDC systems, programmers must build out every potential scenario and use custom functions. In Veeva EDC, the use of dynamics, a simplified study schedule editor, and the obsolescence of custom functions allow teams to design the study they need.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n

\n
\n
\n\t\t\t\t\t<\/a><\/p>\n
\n\t\t\t\t\t\tBlog<\/a>
\n\t\t\t\t\t\tRead how Veeva EDC can simplify your trial designs.\n\t\t\t\t\t<\/div>\n<\/p><\/div>\n
\n\t\t\t\t\t<\/a><\/p>\n
\n\t\t\t\t\t\tVideo<\/a>
\n\t\t\t\t\t\tVeeva EDC eliminates the need for custom functions.\n\t\t\t\t\t<\/div>\n<\/p><\/div>\n
\n\t\t\t\t\t<\/a><\/p>\n
\n\t\t\t\t\t\tWhite Paper<\/a>
\n\t\t\t\t\t\tFind out what to look for in an EDC to support complex study designs and minimize data entry for sites.\n\t\t\t\t\t<\/div>\n<\/p><\/div>\n
\n\t\t\t\t\t<\/a><\/p>\n
\n\t\t\t\t\t\tWebinar<\/a>
\n\t\t\t\t\t\tSee how the Parker Institute for Cancer Immunotherapy (PICI) builds complex platform trials with ease\n\t\t\t\t\t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n
\n
\n
<\/div>\n<\/p><\/div>\n

\t\t<\/p>\n

\n
\n
\n\t\t\t\t\t\n\t\t\t\t<\/div>\n
\n\t\t\t\t\t<\/a><\/p>\n

COLLECT<\/h3>\n

Documenting the Patient Journey in Oncology Trials<\/h2>\n

Oncology trials involve complicated patient journeys that make for complicated CRFs. Veeva EDC addresses these complexities by simplifying how patient visits and forms are created, guiding sites through error-free data entry, and simplifying processes for local labs.<\/p>\n

In traditional EDC systems, sites must figure out how to navigate the CRFs and then intuit the correct way to enter data. In Veeva EDC, the proper use of dynamics will alleviate that issue. And we\u2019ve simplified elements like RECIST (Response Evaluation Criteria in Solid Tumors) data collection and managing local lab reference ranges.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n

\n
\n
\n\t\t\t\t\t<\/a><\/p>\n
\n\t\t\t\t\t\tBlog<\/a>
\n\t\t\t\t\t\tFind out how to overcome the challenges of data collection in oncology trials.\n\t\t\t\t\t<\/div>\n<\/p><\/div>\n
\n\t\t\t\t<\/a><\/p>\n
\n\t\t\t\t\t\tBlog<\/a>
\n\t\t\t\t\t\tLearn how to simplify data collection with progressive display.\n\t\t\t\t\t<\/div>\n<\/p><\/div>\n
\n\t\t\t\t\t